A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

Scientists suggest understanding ecDNA’s role in pancreatic cancer could potentially guide future strategies for making ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced additional results from the successful VERIFI study of its next-generation pancreatic cancer test, ...

Pancreatic cancer is a serious illness that starts in the pancreas, an organ located behind the stomach. The pancreas is ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...